🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the manufacturers of Tylenol, asserting the companies hid safety concerns that the drug created to pediatric brain development.

The lawsuit arrives a month after President Donald Trump publicized an unsubstantiated connection between consuming acetaminophen - alternatively called paracetamol - while pregnant and autism in children.

The attorney general is taking legal action against the pharmaceutical giant, which formerly manufactured the drug, the exclusive pain medication approved for pregnant women, and the current manufacturer, which now manufacturers it.

In a declaration, he said they "deceived the public by profiting off of discomfort and pushing pills regardless of the dangers."

Kenvue says there is no credible evidence tying acetaminophen to autism.

"These companies misled for generations, intentionally threatening numerous people to increase profits," Paxton, from the Republican party, declared.

The manufacturer commented that it was "deeply concerned by the spread of false claims on the security of acetaminophen and the likely effects that could have on the welfare of US mothers and children."

On its online platform, Kenvue also said it had "continuously evaluated the pertinent research and there is lacking reliable evidence that demonstrates a proven link between taking acetaminophen and autism."

Associations speaking for medical professionals and health professionals concur.

The leading OB-GYN organization has stated paracetamol - the main ingredient in Tylenol - is one of the few options for women during pregnancy to address pain and elevated temperature, which can pose major wellness concerns if ignored.

"In multiple decades of studies on the use of paracetamol in gestation, not a single reputable study has conclusively proven that the consumption of acetaminophen in any stage of pregnancy leads to neurodevelopmental disorders in children," the organization stated.

The court filing cites recent announcements from the Trump administration in asserting the drug is allegedly unsafe.

Recently, the former president raised alarms from public health officials when he instructed women during pregnancy to "resist strongly" not to use acetaminophen when ill.

Federal regulators then released a statement that physicians should consider limiting the usage of acetaminophen, while also mentioning that "a proven link" between the drug and autism spectrum disorder in young ones has remains unverified.

The Health Department head RFK Jr, who oversees the Food and Drug Administration, had pledged in April to conduct "a massive testing and research effort" that would establish the origin of autism spectrum disorder in a short period.

But authorities advised that discovering a sole reason of autism - thought by researchers to be the consequence of a complex mix of inherited and environmental factors - would be difficult.

Autism is a type of enduring cognitive variation and disability that impacts how individuals encounter and relate to the surroundings, and is recognized using doctors' observations.

In his lawsuit, the attorney general - who supports Trump who is seeking the Senate - alleges Kenvue and Johnson & Johnson "intentionally overlooked and tried to quiet the research" around paracetamol and autism.

The case seeks to make the companies "eliminate any marketing or advertising" that states acetaminophen is secure for pregnant women.

This legal action echoes the complaints of a group of parents of minors with autism and attention deficit hyperactivity disorder who took legal action against the manufacturers of acetaminophen in 2022.

A federal judge threw out the lawsuit, stating research from the plaintiffs' authorities was not conclusive.